Is NVIV or JEPQ a better dividend investment in 2026?

NVIV currently yields 623.64% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: NVIV offers higher current income.

What is the dividend yield difference between NVIV and JEPQ?

NVIV has a forward dividend yield of 623.64% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 612.54 percentage points.

Home › Compare › NVIV vs JEPQ

NVIV vs JEPQ: Dividend Comparison 2026

NVIV yields 623.64% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NVIV wins by $353147.41M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NVIV

● Live price

623.64%

Share price

$0.32

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$353147.46M

Annual income

$268,464,858,212.91

Full NVIV calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — NVIV vs JEPQ

📍 NVIV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NVIV	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NVIV + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NVIV pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIV

Annual income on $10K today (after 15% tax)

$53,009.04/yr

After 10yr DRIP, annual income (after tax)

$228,195,129,480.97/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, NVIV beats the other by $228,195,127,651.27/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIV + JEPQ for your $10,000?

NVIV: 50%JEPQ: 50%

100% JEPQ50/50100% NVIV

Portfolio after 10yr

$176573.75M

Annual income

$134,232,430,182.75/yr

Blended yield

76.02%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NVIV right now

NVIV

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-38.6

Piotroski

2/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIV buys

JEPQ buys

No recent congressional trades found for NVIV or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNVIVJEPQ

Forward yield	623.64% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$353147.46M ✓	$44.8K
Annual income after 10y	$268,464,858,212.91 ✓	$2,152.59
Total dividends collected	$346135.20M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: NVIV vs JEPQ ($10,000, DRIP)

Year	NVIV Portfolio	NVIV Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$73,064	$62,363.58	$11,930	$1,110.39	+$61.1K → NVIV
2	$504,020	$425,841.72	$14,133	$1,224.34	+$489.9K → NVIV
3	$3,284,735	$2,745,434.16	$16,632	$1,340.46	+$3.27M → NVIV
4	$20,236,353	$16,721,686.56	$19,454	$1,457.97	+$20.22M → NVIV
5	$117,931,146	$96,278,247.94	$22,626	$1,576.08	+$117.91M → NVIV
6	$650,559,742	$524,373,415.78	$26,175	$1,694.09	+$650.53M → NVIV
7	$3,399,531,572	$2,703,432,648.58	$30,133	$1,811.32	+$3399.50M → NVIV
8	$16,840,226,624	$13,202,727,840.99	$34,531	$1,927.17	+$16840.19M → NVIV
9	$79,142,617,279	$61,123,574,791.73	$39,403	$2,041.08	+$79142.58M → NVIV
10	$353,147,458,701	$268,464,858,212.91	$44,787	$2,152.59	+$353147.41M → NVIV

NVIV vs JEPQ: Complete Analysis 2026

NVIV — Stock

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIV Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this NVIV vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIV vs SCHD NVIV vs JEPI NVIV vs O NVIV vs KO NVIV vs MAIN NVIV vs XYLD NVIV vs QYLD NVIV vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.